Skip to main content
SpringerLink
Log in

Benefits and Risks of Hormone Replacement Therapy

  • Chapter
Estrogens, Progestins, and Their Antagonists

Part of the book series: Hormones in Health and Disease ((HHD))

  • 177 Accesses

Abstract

As life expectancy increased in the early twentieth century, more and more women began living past menopause and experiencing many of the symptoms that accompany the end of the reproductive years. Researchers soon recognized that many of these symptoms were caused by the reduction in estrogen levels that accompanied menopause. It was proposed that, by replacing the missing estrogen, the symptoms of menopause could be alleviated. Thus, the concept of estrogen replacement therapy (ERT) was born.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adelman SJ (1994): Anti-atherogenic activities of conjugated equine estrogen components. AJH 7(4 Part 2):71 A. Abstract.

    Google Scholar 

  • Alzheimer’s Association (1994): Alzheimer’s Disease Fact Sheet. Chicago: Alzheimers Association. Document no. INQ 229Z.

    Google Scholar 

  • American Cancer Society (1994): Cancer Facts and Figures. Atlanta: American Cancer Society. Publication no. 5008.94.

    Google Scholar 

  • American College of Obstetricians and Gynecologists (ACOG) (1993): Osteoporosis. Int J Gynecol Obstet 41:291–297.

    Google Scholar 

  • Angell M (1993): Caring for women’s health—What is the problem?. N Engl J Med 329:271–272. Editorial.

    PubMed  CAS  Google Scholar 

  • Archer DF, Pickar JH, Bottiglioni F, et al (1994): Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol 83:686–692.

    PubMed  CAS  Google Scholar 

  • Aronson MK, OOi WL, Morgenstern H, et al (1990): Women, myocardial infarction, and dementia in the very old. Neurology 40:1102–1106.

    PubMed  CAS  Google Scholar 

  • Bachmann GA (1994): Vulvovaginal complaints. In: Lobo RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. New York: Raven Press, pp. 137–151.

    Google Scholar 

  • Belchetz PE (1994): Hormonal treatment of postmenopausal women. N Engl J Med 330:1062–1071.

    PubMed  CAS  Google Scholar 

  • Bewtra C, Kable WT, Gallagher JC (1988): Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin. J Repro Med 33:205–208.

    CAS  Google Scholar 

  • Bostick RM, Potter JD, Kushi LH, et al (1994): Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5:38–52.

    PubMed  CAS  Google Scholar 

  • Brinton LA, Hoover RN, and the Endometrial Cancer Collaborative Group (1993): Estrogen replacement therapy and endometrial cancer risk: Unresolved issues. Obstet Gynecol 81:265–271.

    PubMed  CAS  Google Scholar 

  • Buchanan M, Gallagher JC, Wilson M, et al (1995): Long term estrogen effect on the skeleton. J Bone Miner Res 10(Suppl 1):Abstract M424.

    Google Scholar 

  • Buee L, Hof PR, Bouras C, et al (1994): Pathological alterations of the cerebral microvasculature in Alzheimer’s disease and related dementing disorders. Acta Neuropathol 87:469–480.

    PubMed  CAS  Google Scholar 

  • Burnett RG (1987): Menopause: All Your Questions Answered. Chicago: Contemporary Books, Inc., p. 3.

    Google Scholar 

  • Bush TL (1990): The epidemiology of cardiovascular disease in postmenopausal women. Ann NY Acad Sci 592:263–271.

    PubMed  CAS  Google Scholar 

  • Bush TL, Barrett-Connor E, Cowan LD, et al (1987): Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study. Circulation. 75:1102–1109.

    PubMed  CAS  Google Scholar 

  • Bush TL, Miller VT (1986): Effects of pharmacologic agents used during menopause. Impact on lipids and lipoproteins. In: Mishell D, ed. Menopause: Physiology and Pharmacology. Chicago: Year Book Medical, pp. 187–208.

    Google Scholar 

  • Butler RNJ, Ahronheim J, Fillet H, et al (1993): Vascular dementia: Stroke prevention takes on new urgency. Geriatrics 48:32–42.

    PubMed  CAS  Google Scholar 

  • Calle EE, Miracle-McMahill HL, Thun MJ, et al (1995): Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 87:517–523.

    PubMed  CAS  Google Scholar 

  • Cardozo LD, Tapp A, Versi E (1987): The lower urinary tract in peri- and postmenopausal women in the urogenital oestrogen deficiency syndrome. In: Semsioe ED, Bonne Eriksen P, eds. The Management of the Menopause and Postmenopausal Years. Lancaster, England: MTP Press, 1976.

    Google Scholar 

  • Chilton Marketing Survey (1994): Hormone Replacement Market: A Monograph.

    Google Scholar 

  • Christiansen C (1994): Postmenopausal bone loss and the risk for osteoporosis. Osteoporosis Int Suppl 1:S47-S51.

    Google Scholar 

  • Christiansen C, Christensen MS, Transbol I (1991, February 28): Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 28:459–461.

    Google Scholar 

  • Christiansen C, Christensen MS, McNair P, et al (1980): Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females. Eur J Clin Invest 10:273–279.

    PubMed  CAS  Google Scholar 

  • Chute CG, Willett WC, Colditz GA, et al (1991): A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 2:201–207.

    PubMed  CAS  Google Scholar 

  • Colditz GA, Hankinson SE, Hunter DJ, et al (1995): The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589–1593.

    PubMed  CAS  Google Scholar 

  • Conference Report (1991): Consensus Development Conference: Prophylaxis and treatment of osteoporosis. Am J Med 90:107–110.

    Google Scholar 

  • Conference Report (1987): Consensus Development Conference: Prophylaxis and treatment of osteoporosis. Br Med J 295:914–915.

    Google Scholar 

  • Consensus Conference (1984): Osteoporosis. JAMA 252:799–802.

    Google Scholar 

  • Cummings SR, Black DM, Nevitt MC, et al (1993): Bone density at various sites for prediction of hip fractures. Lancet 341:72–75.

    PubMed  CAS  Google Scholar 

  • Cummings SR, Black DM, Nevitt MC, et al (1990): Appendicular bone density and age predict hip fracture in women. JAMA 263:665–668.

    PubMed  CAS  Google Scholar 

  • Deligdisch L (1991): Endometrial hyperplasia and endometrial adenocarcinoma. In: Altchek A, Deligdisch L, eds. The Uterus: Pathology, Diagnosis, and Management. New York: Springer Verlag, pp. 84–101.

    Google Scholar 

  • Delmas PD (1990): Clinical use of biochemical markers of bone remodeling in osteoporosis. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. Third International Symposium on Osteoporosis, Copenhagen, Denmark, 14–20 October 1990. Osteopress ApS, pp. 450–458.

    Google Scholar 

  • Dempster DW, Lindsay R (1993): Pathogenesis of osteoporosis. Lancet 341:797–805.

    PubMed  CAS  Google Scholar 

  • Devor M, Barrett-Connor E, Renvall M, et al (1992): Estrogen replacement therapy and the risk of venous thrombosis. Am J Med 92:275–282.

    PubMed  CAS  Google Scholar 

  • Ditkoff EC, Crary WG, Cristo M, et al (1991): Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78:991–995.

    PubMed  CAS  Google Scholar 

  • Dupont WD, Page DL (1991): Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 151:67–72.

    PubMed  CAS  Google Scholar 

  • Eaker ED, Castelli WP (1987): Coronary heart disease and its risk factors among women in the Framingham Study. In: Eaker ED, Packard B, Wenger NK, et al, eds. Coronary Heart Disease in Women. New York: Haymarket Doyma, pp. 122–130.

    Google Scholar 

  • Eaker ED, Packard B, Thom EJ (1989): Epidemiology and risk factors for coronary heart disease in women. In: Douglas PS, ed. Heart Disease in Women. Philadelphia: F.A. Davis, pp. 129–145.

    Google Scholar 

  • Ettinger, B, Friedman, GD, Bush T, Quiesenberry, CP (1996): Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 87:6–12.

    PubMed  CAS  Google Scholar 

  • Ettinger B, Grady D (1993): The waning effect of postmenopausal estrogen therapy on osteoporosis. N Engl J Med 329:1192–1193. Editorial.

    PubMed  CAS  Google Scholar 

  • Ettinger B, Genant HK, Steiger P, et al (1992): Low-dosage micronized 17-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 166:479–488.

    PubMed  CAS  Google Scholar 

  • Ettinger B, Genant HK, Cann CE (1985): Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 102:319–324.

    PubMed  CAS  Google Scholar 

  • Fantl JA, Cardozo L, McClish DK, et al (1994): Estrogen therapy in the management of urinary incontinence in postmenopausal women: A meta-analysis. First Report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 83:12–18.

    PubMed  CAS  Google Scholar 

  • Felson DT, Zhang Y, Hannan MT, et al (1993): The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 329:1141–1146.

    PubMed  CAS  Google Scholar 

  • Ferris GM (1993): Alteration in female sex hormones: Their effect on oral tissues and dental treatment. Compend Contin Educ Dent 14:1558–1570.

    CAS  Google Scholar 

  • Fillit H, Weinreb H, Cholst I, et al (1986): Observations in a preliminary open trial of estradiol therapy for senile dementia—Alzheimer’s type. Psychoneuroendocrinology 11:337–345.

    PubMed  CAS  Google Scholar 

  • Finucane FF, Madans JH, Bush TL, et al (1993): Decreased risk of stroke among postmenopausal hormone users. Arch Intern Med 153:73–79.

    PubMed  CAS  Google Scholar 

  • Funk JL, Mortel KF, Meyer JS (1991): Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women. Dementia 2:268–272.

    Google Scholar 

  • Furner SE, Davis FG, Nelson RL, et al (1989): A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 49:4936–4940.

    PubMed  CAS  Google Scholar 

  • Furuhjelm M, Fedor-Freybergh P (1976): The influence of estrogens on the psyche in climacteric and postmenopausal women. In: van Kepp, ed. Consensus on Menopause Research. Baltimore: University Park Press, pp. 84–93.

    Google Scholar 

  • Gallagher JC, Bay link D (1990): Effect of estrone sulfate on bone mineral density of the femoral neck and spine. Presented at the Twelfth Annual Meeting of the American Society for Bone and Mineral Research, August 28–31, 1990, Atlanta, GA. J Bone Min Res 5(Suppl 2):Abstract 802.

    Google Scholar 

  • Gallagher JC, Goldgar D, Moy A (1987): Total bone calcium in normal women: Effect of age and menopause status. J Bone Miner Res 2:491–496.

    PubMed  CAS  Google Scholar 

  • Gambrell RD Jr (1992): Update on hormone replacement therapy. Am Fam Phys 46 (Suppl):87S-96S.

    Google Scholar 

  • Gambrell RD Jr (1989): Estrogen Replacement Therapy User Guide. Dallas: Essential Medical Information Systems, Inc.

    Google Scholar 

  • Gambrell RD Jr (1986): Prevention of endometrial cancer with progestins. Maturitas 8:159–168.

    PubMed  Google Scholar 

  • Gambrell RD Jr, Massey FM, Castaneda TA, et al (1979): Reduced incidence of endometrial cancer among postmenopausal women treated with progestins. J Am Geriatrics Soc 27:389–394.

    Google Scholar 

  • Gaspard UJ, Gottal J-M, van den Brie A (1995): Postmenopausal changes of lipid and glucose metabolism: A review of their main aspects. Maturitas 21:171–178.

    PubMed  CAS  Google Scholar 

  • Genant HK, Cann DE, Ettinger B, et al (1982): Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97:699–705.

    PubMed  CAS  Google Scholar 

  • Gerhardsson deVerdier M, London S (1992): Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes and Control 3:355–360.

    CAS  Google Scholar 

  • Gertz BJ, Hanson DA, Quan H, et al (1994): Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 9:135–142.

    PubMed  CAS  Google Scholar 

  • Glueck CJ, Lang J, Hamer T, et al (1994): Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 123:59–64.

    PubMed  CAS  Google Scholar 

  • Gordon DJ, Probstfield JL, Garrison RJ, et al (1989): High-density lipoprotein cholesterol and cardiovascular disease. Circulation 79:8–15.

    PubMed  CAS  Google Scholar 

  • Gordon T, Kannel WB, Hjortland MC, et al (1978): Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 89:157–161.

    PubMed  CAS  Google Scholar 

  • Gorodeski Gl, Utian WH (1994): Epidemiology and risk factors of cardiovascular disease in postmenopausal women. In: Lobo RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. New York: Raven Press, pp. 199–221.

    Google Scholar 

  • Gray LA Sr, Christopherson WM, Hoover RN (1977): Estrogens and endometrial carcinoma. Obstet Gynecol 49:385.

    PubMed  Google Scholar 

  • Greenspan SL, Maitland LA, Krasnow MB, et al (1993): Femoral bone loss progresses with age in elderly women. J Bone Miner Res 8(Suppl 1):Abstract 147.

    Google Scholar 

  • Hackman BW, Gailbraith D (1976): Replacement therapy and piperazinc oestrone sulphate (“Harmogen”) and its effects on memory. Curr Med Res Opin 4:303–306.

    PubMed  CAS  Google Scholar 

  • Hammond CB, Jelovsek FR, Lee KL (1979): Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol 133:537–547.

    PubMed  CAS  Google Scholar 

  • Hannan MT, Felson DT, Anderson J (1992): Bone mineral density in elderly men and women: Results from the Framingham Osteoporosis Study. J Bone Miner Res 7:547–553.

    PubMed  CAS  Google Scholar 

  • Hanson DA, Weis MAE, Bollen AM, et al (1992): A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1251–1258.

    PubMed  CAS  Google Scholar 

  • Harlap S (1992): The benefits and risks of hormone replacement therapy: An epidemiologic overview. Am J Obstet Gynecol 166:1986–1992.

    PubMed  CAS  Google Scholar 

  • Heineck JW (1991): Free radical modification of low density lipoproteins: Mechanisms and biological consequences. Free Rad Biol Med 3:65–73.

    Google Scholar 

  • Henderson VW, Buck waiter JG (1994): Cognitive deficits of men and women with Alzheimer’s disease. Neurology 44:90–96.

    PubMed  CAS  Google Scholar 

  • Henderson VW, Paganini-Hill A, Emanuel CK, et al (1994): Estrogen replacement therapy in older women: Comparisons between Alzheimer’s disease cases and nondemented control subjects.Arch Neurol 51:896–900.

    CAS  Google Scholar 

  • Henderson BE, Paganini-Hill A, Ross RK (1988): Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 159:312–317.

    PubMed  CAS  Google Scholar 

  • Hernandes Avila M, Walker AM, Jick H (1990): Use of replacement estrogens and the risk of myocardial infarction. Epidemiology 1:128–133.

    Google Scholar 

  • Honjo H, Ogino Y, Naitoh K, et al (1989): In vivo effects by estrone sulfate on the central nervous system—senile dementia (Alzheimer’s typt). J Steroid Biochem 34:521–525.

    PubMed  CAS  Google Scholar 

  • Horwitz RI, Feinstein AR (1978): Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med 299:1089.

    PubMed  CAS  Google Scholar 

  • Hui SL, Slemenda CW, Johnston CC Jr (1988): Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804–1809.

    PubMed  CAS  Google Scholar 

  • Iosif CS, Bekassy Z (1984): Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 63:257–260.

    CAS  Google Scholar 

  • Jacobs EJ, White E, Weiss NS (1994): Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes and Control 5:359–366.

    PubMed  CAS  Google Scholar 

  • Jansson G (1991): Oestrogen-induced enhancement of myeloperoxidase activity in human leukocytes: A possible cause of oxidative stress in inflammatory cells. Free Rad Res Comm 14:195–208.

    CAS  Google Scholar 

  • Jeffcoat MK, Chestnut CH (1993): Systemic osteoporosis and oral bone loss. JADA 124:49–56.

    PubMed  CAS  Google Scholar 

  • Jensen J, Nilas L, Christiansen C (1990): Influence of menopause on serum lipids and lipoproteins. Maturitas 12:321–331.

    PubMed  CAS  Google Scholar 

  • Jick H, Watkins RN, Hunder JR, et al (1979): Replacement estrogens and endometrial cancer. N Engl J Med 300:218.

    PubMed  CAS  Google Scholar 

  • Judd HL, Meldrum DR (1981): Physiology and pathophysiology of menstruation and menopause. In: Romney SL, Gray MJ, Little AB, et al, eds. Gynecology and Obstetrics: The Health Care of Women. 2nd ed. New York: McGraw-Hill, pp. 885–907.

    Google Scholar 

  • Kannel WB, Wolf PA, Castelli WP, et al (1987): Fibrinogen and risk of cardiovascular disease. JAMA 258:1183–1186.

    PubMed  CAS  Google Scholar 

  • Kannel WB, Hjortland MC, McNamara PM, et al (1976): Menopause and risk of cardiovascular disease: The Framingham Study. Ann Intern Med 85:447–452.

    PubMed  CAS  Google Scholar 

  • Kiel DP (1994): New strategies to prevent hip fracture. Hosp Pract Feb 15:47–54.

    Google Scholar 

  • Klaiber EL, Broverman DM, Vogel W, et al (1979): Estrogen therapy for severe persistent depression in women. Arch Gen Psychiatry 36:550–554.

    PubMed  CAS  Google Scholar 

  • Krall EA, Dawson-Hughes B, Papas A, et al (1994). Tooth loss and skeletal bone density in healthy postmenopausal women. Osteoporosis Int 4:104–109.

    CAS  Google Scholar 

  • Leather AT, Studd JWW (1991): Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestin therapy in postmenopausal women. Obstet Gynecol 78:1008–1010.

    PubMed  CAS  Google Scholar 

  • Lindsay R, Cosman F, Nieves J (1993): Estrogen: Effects and actions in osteoporosis. Osteoporosis Int (Suppl 1):S150-S152.

    Google Scholar 

  • Lindsay R (1992): Osteoporosis: A Guide to Diagnosis, Prevention, and Treatment. New York: Raven Press, p. 18.

    Google Scholar 

  • Lindsay R, Tohme J (1990): Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 75:290–295.

    Google Scholar 

  • Lindsay R (1987): Estrogen therapy in the prevention and management of osteoporosis. Am J Obstet Gynecol 156:347–351.

    Google Scholar 

  • Lindsay R, Hart DM, Clark DM (1984): The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:759–763.

    PubMed  CAS  Google Scholar 

  • Lindsay R, Hart DM, Purdie D, et al (1978): Comparative effects of oestrogen and a progestin on bone loss in postmenopausal women. Clin Sci Molecular Med 54:193–195.

    CAS  Google Scholar 

  • Lindsay R, Hart DM, Aitken JM, et al (1976, May 15): Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1038–1041.

    Google Scholar 

  • Lobo RA, Pickar JH, Wild RA, et al (1994): Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol 84:987–995.

    PubMed  CAS  Google Scholar 

  • Lobo RA, Speroff L (1994): International consensus conference on postmenopausal hormone therapy and the cardiovascular system. Fertil Steril 61:592–595. Editorial.

    PubMed  CAS  Google Scholar 

  • Lobo RA (1991): Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endo Metab 73:925–930.

    CAS  Google Scholar 

  • Lueg MC (1988): Postmenopausal osteoporosis: Treatment with low dose sodium fluoride and estrogen. S Med J 81:597–600.

    CAS  Google Scholar 

  • Lufkin EG, Wahner HW, O’Fallon WM, et al (1992): Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1–9.

    PubMed  CAS  Google Scholar 

  • Mack TM, Pike MC, Henderson BE, et al (1976): Estrogens and endometrial cancer in a retirement community. N Engl J Med 294:1262.

    PubMed  CAS  Google Scholar 

  • Maddox MA (1992): Women at midlife: Hormone replacement therapy. Nursing Clin North Am 27:959–969.

    CAS  Google Scholar 

  • Marcus R, for the PEPI Trial Investigators (1995): Effects of replacement therapies on bone mineral density (BMD): Results from the Postmenopausal Estrogen and Progestin Interventions Trial. J Bone Miner Res 10(Suppl l):Abstract P276.

    Google Scholar 

  • Marcus R (1994): The relationship of estrogen to bone health. In: Marcus R, ed. Osteoporosis. Boston: Blackwell Scientific Publications, pp. 293–308.

    Google Scholar 

  • Maziere C, Auclair M, Ronveaux MF, et al (1991): Estrogens inhibit copper and cell-mediated modification of low-density lipoprotein. Atherosclerosis 89:175–182.

    PubMed  CAS  Google Scholar 

  • McDonald TW, Annegers JF, O’Fallon WM, et al (1977): Exogenous estrogen and endometrial carcinoma: Case-control and incidence study. Am J Obstet Gynecol 127:572.

    PubMed  CAS  Google Scholar 

  • Meade TW, Mellows S, Brozovic M, et al (1986): Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 2:533–537.

    PubMed  CAS  Google Scholar 

  • Melton LJ III, Eddy DM, Johnston CC Jr (1990): Screening for osteoporosis. Ann Intern Med 112:516–528.

    PubMed  Google Scholar 

  • Miller CG, Herd RJM, Fogelman I (1993): Ultrasonic velocity measurements through the calcaneus: Which velocity should be measured? Osteoporosis Int 3:31–35.

    CAS  Google Scholar 

  • Miller VT, Muesing RA, LaRosa JC, et al (1994): Quantitative and qualitative changes in lipids, lipoproteins, appolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin. Obstet Gynecol 83:173–179.

    PubMed  CAS  Google Scholar 

  • Mooradian AD (1993): Antioxidant properties of steroids. J Steroid Biochem Molec Biol 45:509–511.

    PubMed  CAS  Google Scholar 

  • Nabulsi AA, Folsom AR, White A, et al (1993): Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328:1069–1075.

    PubMed  CAS  Google Scholar 

  • Natchtigall LE (1990): Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol 75(Suppl):77S-80S.

    Google Scholar 

  • Natchtigall L, Rattner Heilman J (1986): Estrogen: The Facts Can Change Your Life. Tucson: The Body Press, p. 18.

    Google Scholar 

  • Newcomb PA, Storer BE (1995): Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 87:1067–1071.

    PubMed  CAS  Google Scholar 

  • Nordin BE, Need AG, Bridges A (1992): Relative contributions of years since menopause, age, and weight to vertebral density in postmenopausal women. J Clin Endo Metab 74:20–23.

    CAS  Google Scholar 

  • Notelovitz M (1993): Osteoporosis: Screening, prevention, and management. Fertil Steril 59:707–725.

    PubMed  CAS  Google Scholar 

  • Ohkura T, Isse K, Akazawa K, et al (1995): Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 6:99–107.

    PubMed  CAS  Google Scholar 

  • Ohkura T, Isse K, Akazawa K, et al (1994): Evaluation of estrogen treatment in female patients with demential of Alzheimer type. Endocrine J 41:361–371.

    CAS  Google Scholar 

  • Oldenhave A, Jaszmann LJB, Haspels AA, et al (1993): Impact of climacteric on well-being: A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 168:772–780.

    PubMed  CAS  Google Scholar 

  • Paganini-Hill A, Henderson VW (1994): Estrogen deficiency and risk of Alzheimer’s disease in women. Am J Epidemiol 140:256–261.

    PubMed  CAS  Google Scholar 

  • Paganini-Hill A, Ross RK, Henderson BE (1988): Postmenopausal oestrogen treatment and stroke: A prospective study. Br Med J 297:519–522.

    CAS  Google Scholar 

  • Parfitt AM, Simon LS, Villanueva AR, et al (1987): Procollagen type I carboxy terminal peptide in serum as a marker of collagen biosynthesis in bone. J Bone Miner Res 2:427–436.

    PubMed  CAS  Google Scholar 

  • Persson I, Adami H-O, Bergkvist L, et al (1989): Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestins: Results of a prospective study. Br Med J 298:147–151.

    CAS  Google Scholar 

  • Potter JD, McMichael A J (1983): Large bowel cancer in women in relation to reproductive and hormonal factors: A case-control study. J Natl Cancer Inst 71:703–709.

    PubMed  CAS  Google Scholar 

  • Prestwood KM, Pilbeam CC, Burleson JA, et al (1994): The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endo Metab 79:366–371.

    CAS  Google Scholar 

  • Psaty BM, Heckbert SR, Atkins D, et al (1994): The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 154:1333–1339.

    PubMed  CAS  Google Scholar 

  • Ravnikar VA (1992): Compliance with hormone replacement therapy: Are women receiving the full impact of hormone replacement therapy preventive health benefits? WHI 2:75–82.

    PubMed  CAS  Google Scholar 

  • Ravnikar VA (1987): Compliance with hormone therapy. Am J Obstet Gynecol 156:1332–1334.

    PubMed  CAS  Google Scholar 

  • Riggs BL, Melton LJ III (1992): The prevention and treatment of osteoporosis. N Engl J Med 327:620–627.

    PubMed  CAS  Google Scholar 

  • Riis BJ, Jensen J, Christiansen C (1987a): Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy. Clin Endocrinol 26:327–334.

    CAS  Google Scholar 

  • Riis BJ, Thomsen K, Strom V, et al (1987b): The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 156:61–65.

    PubMed  CAS  Google Scholar 

  • Rosenberg L, Werler MM, Kaufman DW, et al (1987): Cancers of the colon and rectum in relation to reproductive factors.Am J Epidemiol 126:760–761. Abstract.

    Google Scholar 

  • Rosen HN, Dresner-Pollak RD, Rosenblatt MM, et al (1994): Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 54:26–29.

    PubMed  CAS  Google Scholar 

  • Ryan PJ, Harrison R, Blake GM, et al (1992): Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynecol 99:325–328.

    CAS  Google Scholar 

  • Sack MN, Rader DJ, Cannon RO III (1994): Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343:269–270.

    PubMed  CAS  Google Scholar 

  • Seibel MJ, Robins SP, Bilezikian JP, et al (1995): Markers of bone metabolism. In: Becker KL, ed. Principles and Practice of Endocrinology and Metabolism. 2nd ed. Philadelphia: J.B. Lippincott, pp. 498–507.

    Google Scholar 

  • Session DR, Kelly AC, Jelelewicz R (1993): Current concepts in estrogen replacement therapy in the menopause. Fertil Steril 59:277–284.

    PubMed  CAS  Google Scholar 

  • Sherwin BB, Gelfand MM (1989): A prospective 1-year study of estrogen and progestin in postmenopausal women: Effects on clinical symptoms and lipoprotein lipids. Obstet Gynecol 73:759–765.

    PubMed  CAS  Google Scholar 

  • Sherwin BB (1988a): Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13:345–357.

    PubMed  CAS  Google Scholar 

  • Sherwin BB (1988b): Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disorders 14:177–187.

    PubMed  CAS  Google Scholar 

  • Skolnick AA (1992): At third meeting, menopause experts make the most of insufficient data. JAMA 268:2483–2485.

    PubMed  CAS  Google Scholar 

  • Slemenda CW (1994): Adult bone loss. In: Marcus R, ed. Osteoporosis. Boston: Blackwell Scientific Publications, pp. 104–124.

    Google Scholar 

  • Smith RNJ, Studd JWW (1994): Estrogens and depression in women. In: Lobo RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. New York: Raven Press, pp. 129–136.

    Google Scholar 

  • Soma MR, Osnago-Gadda I, Paoletti R, et al (1993): The lowering of lipoprotein [a] induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med 153:1462–1468.

    PubMed  CAS  Google Scholar 

  • Soules MR and Bremmer WJ (1982): The Menopause and Climacteric: Endocrinologic Basis and Associated Symptomatology. Journal of the American Geriatrics Society 30:548.

    Google Scholar 

  • Speroff L (1993): Menopause and hormone replacement therapy. Clin Geriatric Med 9:33–55.

    CAS  Google Scholar 

  • Stampfer MJ, Colditz GA (1991): Estrogen replacement therapy and coronary hear disease: A quantitative assessment of the epidemiologic evidence. Prev Med 20:47–63.

    PubMed  CAS  Google Scholar 

  • Stampfer MJ, Colditz GA, Willett WC, et al (1991): Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses’ Health Study. N Engl J Med 325:756–762.

    PubMed  CAS  Google Scholar 

  • Stampfer MJ, Willett WC, Colditz GA, et al (1985): A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313:1038–1049.

    Google Scholar 

  • Stanford JL, Weiss NL, Voigt LF, et al (1995): Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 274:137–142.

    PubMed  CAS  Google Scholar 

  • Stevenson JC (1990): Pathogenesis, prevention, and treatment of osteoporosis. Obstet Gynecol 75(Suppl):36S-41S.

    PubMed  CAS  Google Scholar 

  • Stevenson JC, Lees B, Devenport M, et al (1989): Determinants of bone density in normal women: Risk factors for future osteoporosis? Br Med J 298:924–928.

    CAS  Google Scholar 

  • Subbiah RMT, Kessel B, Agrawal M, et al (1993): Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endo Metab 77:1095–1097.

    CAS  Google Scholar 

  • Sullivan JM, van der Zwaag R, Hughes JP, et al (1990): Estrogen replacement and coronary artery disease: Effect on survival in postmenopausal women. Arch Intern Med 150:2557–2562.

    PubMed  CAS  Google Scholar 

  • te Velde ER, van Leusden HAIM (1994): Hormonal treatment for the climacteric: Alleviation of symptoms and prevention of postmenopausal disease. Lancet 343:654–658.

    Google Scholar 

  • U.S. Congress, Office of Technology Assessment (1987): Losing a Million Minds: Confronting the Tragedy of Alzheimer’s Disease and Other Dementias. OTA-BA-323. Washington, DC: Government Printing Office.

    Google Scholar 

  • Van Hartesveldt C, Joyce JN (1986): Effects of estrogen on the basal ganglia. Neurosci Behavioral Rev 10:1–14.

    Google Scholar 

  • Vanhulle G, Demol R (1976): A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women. In: van Kepp, ed. Consensus on Menopause Research. Baltimore: University Park Press, pp. 94–99.

    Google Scholar 

  • Voigt LF, Weiss NS, Chu J, et al (1991): Progestin supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 328:274–277.

    Google Scholar 

  • Wasnich RD, Ross PD, Heilbrun LK, et al (1985): Prediction of postmenopausal fracture risk with use of bone mineral measurements. Am J Obstet Gynecol 153:745–751.

    PubMed  CAS  Google Scholar 

  • Weiss NS, Szekely DR, English DR, et al (1979): Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA 242:261.

    PubMed  CAS  Google Scholar 

  • Wenger N, Speroff L, Packard B (1993): Cardiovascular health and disease in women. N Engl J Med 329:247–256.

    PubMed  CAS  Google Scholar 

  • Whitehead MI, McQueen J, Beard RJ (1977): Effects of cyclic oestrogen therapy and sequential oestrogen/progestin therapy on the endometrium of postmenopausal women. Acta Obstet Gynecol Scand 65(Suppl):91–101.

    CAS  Google Scholar 

  • Wilcox JC, Hodis HN, Hwang J, et al (1995): The biological effects of individual estrogen components in conjugated equine (CE) estrogens and their possible modulation of insulin resistance and oxidation of LDL. J Soc Gynecol Invest 2:153. Abstract.

    Google Scholar 

  • Wild RA, Taylor EL, Knehans A (1995): The gynecologist and the prevention of cardiovascular disease. Am J Obstet Gynecol 172:1–13.

    PubMed  CAS  Google Scholar 

  • Willis DB, Calle EE, Miracle-McMahill H, et al (1996): Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal US. women. Cancer Causes and Control (in press).

    Google Scholar 

  • Wilson PWF, Garrison RJ, Castelli WP (1985): Postmenopausal estrogen user, cigarette smoking, and cardiovascular morbidity in women over 50. N Engl J Med 313:1038–1043.

    PubMed  CAS  Google Scholar 

  • Wolf PH, Madans JH, Finucane FF (1991): Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: Evidence from a national cohort. Am J Obstet Gynecol 164:489–494.

    PubMed  CAS  Google Scholar 

  • Woodruff JD, Pickar JH, for the Menopause Study Group (1994): Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogestone acetate or conjugated estrogens alone. Am J Obstet Gynecol 170:1213–1223.

    PubMed  CAS  Google Scholar 

  • The Writing Group for the PEPI Trial (1995): Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199–208.

    Google Scholar 

  • Ziel HK, Finkel WD (1975): Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293:1167.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wyeth-Ayerst Laboratories, East Lancaster Avenue, 555, St. Davids, PA, USA

    Raymond Klein

  2. Wyeth-Ayerst Laboratories, East Lancaster Avenue, 555, Radnor, PA, USA

    Laini Berlin

Authors
  1. Raymond Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laini Berlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Kentucky Medical Center, 800 Rose Street, 40536-0084, Lexington, KY, USA

    Edward J. Pavlik

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Birkhäuser Boston

About this chapter

Cite this chapter

Klein, R., Berlin, L. (1997). Benefits and Risks of Hormone Replacement Therapy. In: Pavlik, E.J. (eds) Estrogens, Progestins, and Their Antagonists. Hormones in Health and Disease. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4096-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4096-9_1

  • Publisher Name: Birkhäuser Boston

  • Print ISBN: 978-1-4612-8650-9

  • Online ISBN: 978-1-4612-4096-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation